Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer

C. Y. Liu, C. H. Wang, T. C. Chen, H. C. Lin, C. T. Yu, H. P. Kuo

Research output: Contribution to journalArticle

136 Citations (Scopus)

Abstract

Monocyte-macrophage series have an important role in host surveillance against cancer. The cytotoxic/cytostatic activity of macrophages is, to a great extent, attributed to the up-regulation of inducible nitric oxide synthase (iNOS) and production of nitric oxide (NO). Here, in 28 patients with primary lung cancer and 20 control subjects, we measured the concentration of exhaled NO and nitrite in epithelial lining fluid (ELF) using a chemiluminescence NO analyser and studied NOS expression in alveolar macrophages (AM) and lung tissues by flow cytometry; immunohistochemical analysis was also undertaken. The mean fluorescence intensity (FI) of iNOS expression in AM was significantly increased in patients with lung cancer (tumour side 263.5 ± 15.2 FI, normal side 232.4 ± 18.6 FI, n = 28) compared with that in control subjects (27.3 ± 3.2 FI; n = 20, P < 0.001). The level of exhaled NO from cancer patients (16.9 ± 0.9 p.p.b.; n = 28) was significantly higher than that in the control group (6.0 ± 0.5 p.p.b.; n = 20, P < 0.001). The level of nitrite was also significantly higher in ELF from cancer patients (tumour side 271.1 ± 28.9 nM and normal side 257.4 ± 19.6 nM vs control subjects 32.9 ± 4.1 nM; P < 0.001). The intensity of iNOS expression in AM was correlated with the level of exhaled NO (r(s) = 0.73, n = 76, P < 0.001) and the nitrite released in ELF (r(s) = 0.56, n = 76, P < 0.001). The nitrite generation of cultured AM from patients with lung cancer was significantly enhanced compared with that of control subjects after culture for 24 h (tumour side 5.75 ± 0.69 and normal side 5.68 ± 0.58 μM per 106 cells vs control group 38.3 ± 3.6 nM per 106 cells; P < 0.001). The distribution of iNOS was identified in AM, tumour-associated macrophages, endothelium, chondrocytes, airway epithelium of both lungs and malignant cells (adenocarcinoma and alveolar cell carcinoma) of cancer patients. cNOS was labelled in alveolar macrophages, endothelial cells and nerve elements from lung tissue. Our results indicate that, in patients with primary lung cancer, the production of NO from alveolar macrophages was increased as a result of the up-regulation of iNOS activity. The increased NO production was not specific to the tumour side and might be attributed to the tumour-associated non-specific immunological and inflammatory processes of the host.

Original languageEnglish
Pages (from-to)534-541
Number of pages8
JournalBritish Journal of Cancer
Volume78
Issue number4
Publication statusPublished - Aug 15 1998
Externally publishedYes

Fingerprint

Nitric Oxide Synthase Type II
Lung Neoplasms
Nitric Oxide
Up-Regulation
Alveolar Macrophages
Neoplasms
Nitrites
Fluorescence
Macrophages
Lung
Bronchiolo-Alveolar Adenocarcinoma
Control Groups
Cytostatic Agents
Chondrocytes
Luminescence
Endothelium
Monocytes
Flow Cytometry
Adenocarcinoma
Epithelium

Keywords

  • Alveolar macrophage
  • Cytotoxicity
  • Lung cancer
  • Nitric oxide
  • Nitric oxide synthase
  • Nitrite

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer. / Liu, C. Y.; Wang, C. H.; Chen, T. C.; Lin, H. C.; Yu, C. T.; Kuo, H. P.

In: British Journal of Cancer, Vol. 78, No. 4, 15.08.1998, p. 534-541.

Research output: Contribution to journalArticle

@article{1249fc541c3e42fbb91c0cd6e180de5d,
title = "Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer",
abstract = "Monocyte-macrophage series have an important role in host surveillance against cancer. The cytotoxic/cytostatic activity of macrophages is, to a great extent, attributed to the up-regulation of inducible nitric oxide synthase (iNOS) and production of nitric oxide (NO). Here, in 28 patients with primary lung cancer and 20 control subjects, we measured the concentration of exhaled NO and nitrite in epithelial lining fluid (ELF) using a chemiluminescence NO analyser and studied NOS expression in alveolar macrophages (AM) and lung tissues by flow cytometry; immunohistochemical analysis was also undertaken. The mean fluorescence intensity (FI) of iNOS expression in AM was significantly increased in patients with lung cancer (tumour side 263.5 ± 15.2 FI, normal side 232.4 ± 18.6 FI, n = 28) compared with that in control subjects (27.3 ± 3.2 FI; n = 20, P < 0.001). The level of exhaled NO from cancer patients (16.9 ± 0.9 p.p.b.; n = 28) was significantly higher than that in the control group (6.0 ± 0.5 p.p.b.; n = 20, P < 0.001). The level of nitrite was also significantly higher in ELF from cancer patients (tumour side 271.1 ± 28.9 nM and normal side 257.4 ± 19.6 nM vs control subjects 32.9 ± 4.1 nM; P < 0.001). The intensity of iNOS expression in AM was correlated with the level of exhaled NO (r(s) = 0.73, n = 76, P < 0.001) and the nitrite released in ELF (r(s) = 0.56, n = 76, P < 0.001). The nitrite generation of cultured AM from patients with lung cancer was significantly enhanced compared with that of control subjects after culture for 24 h (tumour side 5.75 ± 0.69 and normal side 5.68 ± 0.58 μM per 106 cells vs control group 38.3 ± 3.6 nM per 106 cells; P < 0.001). The distribution of iNOS was identified in AM, tumour-associated macrophages, endothelium, chondrocytes, airway epithelium of both lungs and malignant cells (adenocarcinoma and alveolar cell carcinoma) of cancer patients. cNOS was labelled in alveolar macrophages, endothelial cells and nerve elements from lung tissue. Our results indicate that, in patients with primary lung cancer, the production of NO from alveolar macrophages was increased as a result of the up-regulation of iNOS activity. The increased NO production was not specific to the tumour side and might be attributed to the tumour-associated non-specific immunological and inflammatory processes of the host.",
keywords = "Alveolar macrophage, Cytotoxicity, Lung cancer, Nitric oxide, Nitric oxide synthase, Nitrite",
author = "Liu, {C. Y.} and Wang, {C. H.} and Chen, {T. C.} and Lin, {H. C.} and Yu, {C. T.} and Kuo, {H. P.}",
year = "1998",
month = "8",
day = "15",
language = "English",
volume = "78",
pages = "534--541",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer

AU - Liu, C. Y.

AU - Wang, C. H.

AU - Chen, T. C.

AU - Lin, H. C.

AU - Yu, C. T.

AU - Kuo, H. P.

PY - 1998/8/15

Y1 - 1998/8/15

N2 - Monocyte-macrophage series have an important role in host surveillance against cancer. The cytotoxic/cytostatic activity of macrophages is, to a great extent, attributed to the up-regulation of inducible nitric oxide synthase (iNOS) and production of nitric oxide (NO). Here, in 28 patients with primary lung cancer and 20 control subjects, we measured the concentration of exhaled NO and nitrite in epithelial lining fluid (ELF) using a chemiluminescence NO analyser and studied NOS expression in alveolar macrophages (AM) and lung tissues by flow cytometry; immunohistochemical analysis was also undertaken. The mean fluorescence intensity (FI) of iNOS expression in AM was significantly increased in patients with lung cancer (tumour side 263.5 ± 15.2 FI, normal side 232.4 ± 18.6 FI, n = 28) compared with that in control subjects (27.3 ± 3.2 FI; n = 20, P < 0.001). The level of exhaled NO from cancer patients (16.9 ± 0.9 p.p.b.; n = 28) was significantly higher than that in the control group (6.0 ± 0.5 p.p.b.; n = 20, P < 0.001). The level of nitrite was also significantly higher in ELF from cancer patients (tumour side 271.1 ± 28.9 nM and normal side 257.4 ± 19.6 nM vs control subjects 32.9 ± 4.1 nM; P < 0.001). The intensity of iNOS expression in AM was correlated with the level of exhaled NO (r(s) = 0.73, n = 76, P < 0.001) and the nitrite released in ELF (r(s) = 0.56, n = 76, P < 0.001). The nitrite generation of cultured AM from patients with lung cancer was significantly enhanced compared with that of control subjects after culture for 24 h (tumour side 5.75 ± 0.69 and normal side 5.68 ± 0.58 μM per 106 cells vs control group 38.3 ± 3.6 nM per 106 cells; P < 0.001). The distribution of iNOS was identified in AM, tumour-associated macrophages, endothelium, chondrocytes, airway epithelium of both lungs and malignant cells (adenocarcinoma and alveolar cell carcinoma) of cancer patients. cNOS was labelled in alveolar macrophages, endothelial cells and nerve elements from lung tissue. Our results indicate that, in patients with primary lung cancer, the production of NO from alveolar macrophages was increased as a result of the up-regulation of iNOS activity. The increased NO production was not specific to the tumour side and might be attributed to the tumour-associated non-specific immunological and inflammatory processes of the host.

AB - Monocyte-macrophage series have an important role in host surveillance against cancer. The cytotoxic/cytostatic activity of macrophages is, to a great extent, attributed to the up-regulation of inducible nitric oxide synthase (iNOS) and production of nitric oxide (NO). Here, in 28 patients with primary lung cancer and 20 control subjects, we measured the concentration of exhaled NO and nitrite in epithelial lining fluid (ELF) using a chemiluminescence NO analyser and studied NOS expression in alveolar macrophages (AM) and lung tissues by flow cytometry; immunohistochemical analysis was also undertaken. The mean fluorescence intensity (FI) of iNOS expression in AM was significantly increased in patients with lung cancer (tumour side 263.5 ± 15.2 FI, normal side 232.4 ± 18.6 FI, n = 28) compared with that in control subjects (27.3 ± 3.2 FI; n = 20, P < 0.001). The level of exhaled NO from cancer patients (16.9 ± 0.9 p.p.b.; n = 28) was significantly higher than that in the control group (6.0 ± 0.5 p.p.b.; n = 20, P < 0.001). The level of nitrite was also significantly higher in ELF from cancer patients (tumour side 271.1 ± 28.9 nM and normal side 257.4 ± 19.6 nM vs control subjects 32.9 ± 4.1 nM; P < 0.001). The intensity of iNOS expression in AM was correlated with the level of exhaled NO (r(s) = 0.73, n = 76, P < 0.001) and the nitrite released in ELF (r(s) = 0.56, n = 76, P < 0.001). The nitrite generation of cultured AM from patients with lung cancer was significantly enhanced compared with that of control subjects after culture for 24 h (tumour side 5.75 ± 0.69 and normal side 5.68 ± 0.58 μM per 106 cells vs control group 38.3 ± 3.6 nM per 106 cells; P < 0.001). The distribution of iNOS was identified in AM, tumour-associated macrophages, endothelium, chondrocytes, airway epithelium of both lungs and malignant cells (adenocarcinoma and alveolar cell carcinoma) of cancer patients. cNOS was labelled in alveolar macrophages, endothelial cells and nerve elements from lung tissue. Our results indicate that, in patients with primary lung cancer, the production of NO from alveolar macrophages was increased as a result of the up-regulation of iNOS activity. The increased NO production was not specific to the tumour side and might be attributed to the tumour-associated non-specific immunological and inflammatory processes of the host.

KW - Alveolar macrophage

KW - Cytotoxicity

KW - Lung cancer

KW - Nitric oxide

KW - Nitric oxide synthase

KW - Nitrite

UR - http://www.scopus.com/inward/record.url?scp=0031827486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031827486&partnerID=8YFLogxK

M3 - Article

VL - 78

SP - 534

EP - 541

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 4

ER -